3 federal incentives driving bioprinted tissue reimbursement in late 2026
Government healthcare agencies in 2026 are shifting from skepticism to active subsidization of 3D bioprinted medical solutions. In a landmark policy update, the Medicare and Medicaid frameworks have officially categorized bioprinted skin and bone grafts as "Essential Regenerative Services." This economic move is designed to lower the long-term costs of chronic disease management, as bioprinted...
0 Commentaires 0 Parts 110 Vue 0 Aperçu
Commandité